JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by COHEN, M.
Right arrow Articles by POCELINKO, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by COHEN, M.
Right arrow Articles by POCELINKO, R.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*PROBENECID
*SODIUM
*SULFISOXAZOLE
Journal of Pharmacology And Experimental Therapeutics, Vol. 185, Issue 3, 703-712, 1973
Copyright © 1973 by American Society for Pharmacology and Experimental Therapeutics


RENAL TRANSPORT MECHANISMS FOR THE EXCRETION OF SULFISOXAZOLE

MICHAEL COHEN 1 and ROBERT POCELINKO 1

1 Departments of Pharmacology and Clinical Pharmacology, Hoffmann-La Roche, Inc., Nutley, New Jersey

The renal handling of sulfisoxazole was evaluated in man and dog with clearance studies and stop-flow analysis. Excretion is altered by urine pH in both species and by urine flow changes in the dog. In dog renal clearance studies, no correlation could be made between the increased filtered load of sulfonamide and its clearance values. Probenecid and dinitrophenol significantly decreased the excretion of sulfisoxazole under conditions of urinary alkalinization. The data from the present clearance studies in man and dog suggest two mechanisms for the renal handling of sulfonamide: passive reabsorption-secretion and active secretion. To test the latter mechanism, stop-flow protocol was utilized in anesthetized dogs. Data from these studies indicate an active secretory transport component in the proximal renal tubule. Furthermore, inhibition of proximal tubular secretion was obtained in the presence of probenecid. On the other hand, tubular reaborption of sulfisoxazole as a passive component was altered by urinary alkalinization but was unaffected by probenecid administration. Therefore, it appears that several mechanisms, i.e., active secretion and passive reabsorption-secretion, are involved in the renal handling of sulfisoxazole under certain laboratory conditions in both man and dogs.

Submitted on September 28, 1972
Accepted on January 29, 1973







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1973 by the American Society for Pharmacology and Experimental Therapeutics.